![Ruth Wolfson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ruth Wolfson
Keine laufenden Positionen mehr
Profil
Ruth Wolfson worked as the Senior Vice President of Quality & Regulatory Affairs at Kamada Ltd. from 2004 to 2018.
Prior to that, she was the Head of Regulatory Affairs at Interpharm Laboratories Ltd. from 1989 to 2004.
Dr. Wolfson received her undergraduate and graduate degrees from The Hebrew University of Jerusalem and her doctorate from the Weizmann Institute of Science.
Ehemalige bekannte Positionen von Ruth Wolfson
| Unternehmen | Position | Ende |
|---|---|---|
| KAMADA LTD. | Technik-/Wissenschafts-/F&E-Leiter | 02.01.2018 |
Interpharm Laboratories Ltd.
 Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases | General Counsel | 01.01.2004 |
Ausbildung von Ruth Wolfson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
35
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kamada Ltd.
 Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
Interpharm Laboratories Ltd.
Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases | Health Technology |
Wählen Sie MarketScreener 
